The Oncology Drugs Industry, valued at USD 198.73 billion in 2022, is poised for substantial growth over the coming years. It is expected to reach USD 471.35 billion by 2030, expanding at a compound annual growth rate (CAGR) of 11.4% from 2023 to 2030. This rapid expansion is driven by increasing cancer prevalence, advancements in drug development, and rising investment in oncology...

The global proteomics market is anticipated to witness substantial growth, with an expected value of USD 70.8 billion by the year 2030. According to recent market analysis, the market size for proteomics was estimated at USD 25.3 billion in 2022, indicating a robust upward trajectory with a Compound Annual Growth Rate (CAGR) of 13.7% during the forecast period from 2023 to 2030....